The consultancy firm GENESIS Biomed a reference in advisory services for R&D&i projects in the biomedical sector, member of CataloniaBio &HealthTech, will close this financial year with a record turnover of €2M, 25% more than in 2022, thanks to an exclusively organic growth strategy and an ambitious national expansion plan.
In 2023, the consultancy, founded by Josep Lluís Falcó and Natalia de la Figuera, has collaborated in more than 60 early-stage R&D&i projects, from accompaniment in the constitution process of spin-offs and startups, the creation of the business plan, valuation of the product through a development plan or creation of the financing plan. The identification in the latter of the financial needs will enable the strategy for raising private funds to be defined, in which the consultancy will also accompany these companies.
So far this year, GENESIS Biomed has taken part in the closure of the €1M round of Renalyse with the Botín Foundation, and is providing support in raising private funds for another three companiesin the sector. And through its vehicle GENESIS Tech Transfer Boost, it has carried out another two transactions, that of the spin-off Retina Read Risk and the startup Spinally Medical, and has a third underway which will be published shortly.
GENESIS Biomed also habitually collaborated with research centres, companies investors and other stakeholders in the biomedical sector, working on strategic plans, analysis of investments, valuations of companies and accompaniment in incubation and acceleration processes, among others.
Since its foundation, in May 2017, the company has done 308 consultancy projects for 260 clients, and has contributed to closing a total of 20 financing rounds, raising more than €68.5M for its clients, with the aim of contributing to the knowledge generated in universities and hospitals materialising in companies that develop innovative solutions to improve people’s health and quality of life.
Inauguration of its new headquarters in the Valencia BioHub and growth of the Madrid office
Within the framework of the ambitious national expansion plan, GENESIS Biomed has opened offices in the BioHub VLC, the first privately managed Spanish business centre dedicated to health and life sciences.
In the words of Josep Lluís Falcó, founder and CEO of the consultancy: The opening of these headquarters is decision of GENESIS Biomed to invest in the Valencian Community which is positioning itself as one of the main clusters in Biomedicine, bringing together a significant number of Health Research Institutes and Research Foundations.
Last September, GENESIS Biomed incorporated the lawyer Antonio Rodríguez Hita as the new Director of the company’s offices opened in Madrid in 2019. The incorporation of Rodriguez Hita will enable GENESIS Biomed to consolidate its expansion in the Community of Madrid, a Community with a large number of companies, billing and investment in R&D and with great potential.
Comments